In May 2022, a bipartisan pair, Rep. Troy Carter (D-La.) and Rep. Guy Reschenthaler (R-Pa.) introduced a never-before-seen bill—the Capital Lending and Investment for Marijuana Businesses Act (“the CLIMB Act”).
The proposed legislation, H.R. 8200, would result in a decrease in the cost of doing business as a cannabis-related business (CRB); the ability for such companies to treat banking, financing, and transactions as a traditional business might; and relief for third-party business services put at risk due to cannabis’ Schedule I status under the federal Controlled Substances Act.
In its own words, the C.LIMB Act intends:
To amend any applicable federal law to permit access to community development, small business, minority development, and any other public or private financial capital sources for investment in and financing of cannabis-related legitimate businesses, and to amend the Securities Exchange Act of 1934 to create a safe harbor for national securities exchanges to list the securities of issuers that are cannabis-related legitimate businesses.
To put it plainly, the CLIMB Act would treat legitimate cannabis and cannabis-related companies the same as any other business where federal law would otherwise interfere with third parties’ ability to provide standard business services (e.g., banking and insurance).
The H.R. 8200 intends for a broad interpretation so that cannabis and cannabis-related companies are put on an even playing field with traditional business operations. Its purpose may be to reduce purchase prices on cannabis products in highly regulated states, to stimulate economic activity by reducing risks to third-parties, to improve the current state of capital markets—there are numerous benefits to this bill that would justify its introduction.
For an idea of the kinds of business activity the bill is designed to protect and expand; the CLIMB Act defines protected cannabis “business assistance” to include:
As you can see, H.R. 8200 intends to cover most if not all standard business services.
Many of the services that fall under “business assistance,” face an unwritten “cannabis tax” up-charge in today’s current market. This results in legitimate cannabis operations paying more for standard business activities (and often receive less in exchange). The “cannabis tax” is most significantly seen as it relates to banking and financing, and insurance coverage. This up-charge is frequently passed down to cannabis consumers by businesses beholden to investors and their fiduciary duties.
The National Association of Insurance Commissioners describes what is at stake in the areas of insurance and finance for cannabis-related businesses (“CRBs”) under current federal law:
CRBs share the same general liability and other risks agricultural and manufacturing businesses face. This includes workplace accidents, damage to property and crop failure. CRBs are especially prone to fires from both wild and internal sources. Some of the biggest risks involve theft, general liability and product liability. Companies functioning within state legality face severe banking restrictions due to federal regulations. It is estimated that approximately 70% of CRBs operate solely as a cash-only business and have no formal relationship with a bank. As a result, CRBs may be forced to handle large sums of cash, subjecting them to a higher risk of theft and increased liability.
Sadly, despite the same needs of your standard legitimate business (e.g., credit card transactions and adequate insurance coverage), cannabis businesses remain exposed and exploited.
The CLIMB Act is an efficient, 7-page bill that would go into effect 180 days after enactment. As of June 23, 2022, the bill still sits in the House Committee on Financial Services.
The bill’s short, narrow, common sense composition and bipartisan support give it a good chance of gaining traction. When cannabis bills become too broad and try to cover too many issues, they tend to get caught up in disputes and discarded for more pressing issues during legislative sessions.
This bill is unlikely to garner opposition from outspoken social equity advocates that have slowed previous legislation, including the S.A.F.E. Banking Act, because third-party services provide a low barrier point of entry for communities impacted by cannabis prohibition to generate wealth within today’s regulated cannabis market.
If stakeholders and top lobbyists—such as the U.S. National Cannabis Council which includes many of the U.S. cannabis market’s major players—get behind H.R. 8200 alongside state and local-level stakeholders, we may just see our first significant law in federal cannabis reform.
Looking to find your medical cannabis in a state that hasn’t yet legalized it? It may be tempting to drive across neighboring state lines with more cannabis-friendly laws. However, the number of states that will authorize qualified patients from out-of-state medical marijuana programs is still relatively small. Which States Accept Out-of-State MMJ Cards? States That…
So you love smoking cannabis, but you’re tired of the same ole rolling papers. Perhaps you recently learned about the potential dangers and risks associated with tobacco blunt wraps and want a healthier option. Let’s explore some rolling paper alternatives that work well for blunts, joints, and spliffs. Types of Rolling Paper to Absolutely Avoid…
Bipolar disorder is a complex condition that impacts millions worldwide, leading to extreme mood swings, intense emotional episodes, and difficulty managing day-to-day life. But there may be some good news for those coping with this mental health issue. According to recent research, cannabis could offer unique benefits as part of an approach to managing bipolar…
As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. In light of this, one…
Despite the fact that the legal cannabis industry is growing, many people are still purchasing from the illicit market. A recent study investigated this matter and found that buying cannabis from the illicit market may be “better” than legal weed. The obvious reasons for choosing the illicit market over the legal market include the likes…
We sat down with the team at TerraLeaf, a medical cannabis dispensary servicing West Virginia, to ask them the Veriheal 5—five questions…
Gone are the days when cannabis was just an occasional treat—today, it’s a powerful source of holistic healing. According to a 2021…
Gaize is mastering the art of cannabis impairment detection. The Missoula, Montana-based company is gearing up for the launch of its first…